Development of REC1: A Reverse Vaccinology-Derived Multi-Epitope Vaccine Candidate Against Brucellosis.

Liu S, Dai Y, Huang F, Gao Z, Chen Z, Long M, Li S

Open source

DOI
10.3390/vaccines14100891
Published
2026 Oct 12
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14100891,
  title = {Development of REC1: A Reverse Vaccinology-Derived Multi-Epitope Vaccine Candidate Against Brucellosis.},
  author = {Liu S and Dai Y and Huang F and Gao Z and Chen Z and Long M and Li S},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14100891},
  url = {https://doi.org/10.3390/vaccines14100891}
}

RIS

TY  - JOUR
TI  - Development of REC1: A Reverse Vaccinology-Derived Multi-Epitope Vaccine Candidate Against Brucellosis.
AU  - Liu S
AU  - Dai Y
AU  - Huang F
AU  - Gao Z
AU  - Chen Z
AU  - Long M
AU  - Li S
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14100891
UR  - https://doi.org/10.3390/vaccines14100891
ER  - 

APA

S, L., Y, D., F, H., Z, G., Z, C., M, L., & S, L. (2026). Development of REC1: A Reverse Vaccinology-Derived Multi-Epitope Vaccine Candidate Against Brucellosis.. Vaccines. https://doi.org/10.3390/vaccines14100891

Source records